======= CANT1 ======= == Gene Information == * **Official Symbol**: CANT1 * **Official Name**: calcium activated nucleotidase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=124583|124583]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8WVQ1|Q8WVQ1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CANT1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CANT1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/613165|Open OMIM]] == Function Summary == * **Entrez Summary**: This protein encoded by this gene belongs to the apyrase family. It functions as a calcium-dependent nucleotidase with a preference for UDP. Mutations in this gene are associated with Desbuquois dysplasia with hand anomalies. Alternatively spliced transcript variants have been noted for this gene.[provided by RefSeq, Mar 2010]. * **UniProt Summary**: Calcium-dependent nucleotidase with a preference for UDP. The order of activity with different substrates is UDP > GDP > UTP > GTP. Has very low activity towards ADP and even lower activity towards ATP. Does not hydrolyze AMP and GMP (PubMed:12234496, PubMed:15248776, PubMed:15006348, PubMed:16835225). Involved in proteoglycan synthesis (PubMed:22539336). {ECO:0000269|PubMed:12234496, ECO:0000269|PubMed:15006348, ECO:0000269|PubMed:15248776, ECO:0000269|PubMed:16835225, ECO:0000269|PubMed:22539336}. |Apyrase| |guanosine-diphosphatase activity| |adenosine-diphosphatase activity| |uridine-diphosphatase activity| |tertiary granule lumen| |specific granule lumen| |proteoglycan biosynthetic process| |Golgi cisterna membrane| |proteoglycan metabolic process| |ficolin-1-rich granule lumen| |positive regulation of I-kappaB kinase/NF-kappaB signaling| |regulation of I-kappaB kinase/NF-kappaB signaling| |glycoprotein biosynthetic process| |glycoprotein metabolic process| |neutrophil degranulation| |neutrophil activation involved in immune response| |neutrophil mediated immunity| |neutrophil activation| |granulocyte activation| |leukocyte degranulation| |myeloid leukocyte mediated immunity| |myeloid cell activation involved in immune response| |myeloid leukocyte activation| |carbohydrate derivative biosynthetic process| |leukocyte activation involved in immune response| |cell activation involved in immune response| |regulated exocytosis| |calcium ion binding| |leukocyte mediated immunity| |exocytosis| |protein homodimerization activity| |leukocyte activation| |endoplasmic reticulum membrane| |secretion by cell| |positive regulation of intracellular signal transduction| |carbohydrate derivative metabolic process| |export from cell| |cell activation| |immune effector process| |secretion| |organonitrogen compound biosynthetic process| |positive regulation of signal transduction| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |immune response| |extracellular region| |vesicle-mediated transport| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|-1.91| ^Gene^Correlation^ |[[:human genes:p:polr2j3|POLR2J3]]|0.413| |[[:human genes:h:hist2h3a|HIST2H3A]]|0.403| |[[:human genes:h:hist2h3c|HIST2H3C]]|0.402| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2258 * **Expression level (log2 read counts)**: 5.76 {{:chemogenomics:nalm6 dist.png?nolink |}}